Job Seekers, Welcome to NBPRS Career Center
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 2545 Jobs
Save Agent
Loading... Please wait.
Idorsia Pharmaceuticals Logo
Idorsia Pharmaceuticals

Cherry Hill, New Jersey

WWF Washington, DC

Washington, D.C.

Massachusetts Institute of Technology

Cambridge, Massachusetts

University of Florida

Gainesville, Florida

Cornell University

Ithaca, New York

Jamestown Management Corporation

New York, New York

New York University School of Professional Studies Logo
New York University School of Professional Studies

New York, New York

The Phillips Collection Logo
The Phillips Collection

Washington, D.C.

CityBridge Education Logo
CityBridge Education

Washington, D.C.

University of Richmond

Richmond, Virginia

Auburn University

Auburn, Alabama

Disney Worldwide Services Inc Logo
Disney Worldwide Services Inc

Celebration, Florida

Robert Wood Johnson Foundaiton

Princeton, New Jersey

Dumbarton Oaks Logo
Dumbarton Oaks

Washington, D.C.

Transportation Intermediaries Association Logo
Transportation Intermediaries Association

Alexandria, VA

American Association of Neurological Surgeons Logo
American Association of Neurological Surgeons

Rolling Meadows, IL

Aging Life Care Association Logo
Aging Life Care Association

Tucson, Arizona

American Physical Therapy Association Logo
American Physical Therapy Association

Alexandria, VA

American Physical Therapy Association Logo
American Physical Therapy Association

Alexandria, VA

American Chemistry Council Logo
American Chemistry Council

Union Station

Loading... Please wait.
Expand Show Other Jobs
Job Saved Save Job
Employer Logo
Association Logo
Global Drug Regulatory Affairs Project Lead
Idorsia Pharmaceuticals
Email Print
Employer Logo
About Idorsia Pharmaceuticals
Idorsia is a high-potential biopharmaceutical company, with an experienced team of over 1,200 highly qualified professionals, a full R&D pipeline, state-of-the-art facilities, and a strong balance sheet – the ideal constellation for bringing successful medicines to the market. We began our operations after demerging from Actelion following its acquisition by Johnson & Johnson in 2017. At that time, approximately 650 talented and engaged employees were transferred to Idorsia, together with the discovery pipeline and early-stage clinical assets. Idorsia is specialized in the discovery and development of small molecules, with the aim of transforming the horizon of therapeutic options. We have a broad, diversified and balanced development pipeline, covering multiple therapeutic areas. Our clinical pipeline comprises 11 assets, 6 of which are in late-stage development, and we expect to see two product launches in two of the largest pharmaceutical markets in the second quarter of 2022. With this in mind, we have built a commercial organization to bring our products to patients. Idorsia is a start-up like no other!
Connections working at Idorsia Pharmaceuticals
Loading. Please wait.
Powered By Naylor Association Solutions